All these clinical studies, although heterogeneity was considerably high [36], have shown that cTnI serum levels were only marginally increased in COVID-19 patients at hospital admission, observing values exceeding the 99 th percentile in the upper reference limit (URL) in 7–17% of hospital admitted positive cases. Here, TNNI3 is linked to COVID-19.